SHOULDER INNOVATIONS INC (SI) Stock Fundamental Analysis
USA - NYSE:SI - US82537J1088 - Common Stock
14.7 USD
0 (0%)
14.6 USD
-0.1 (-0.68%)
We assign a fundamental rating of 5 out of 10 to SI. SI was compared to 188 industry peers in the Health Care Equipment & Supplies industry. SI has an excellent financial health rating, but there are some minor concerns on its profitability. SI has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year SI was profitable.
Each year in the past 5 years SI has been profitable.
SI had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
The Return On Assets of SI (1.78%) is better than 75.13% of its industry peers.
SI's Return On Equity of 14.79% is amongst the best of the industry. SI outperforms 89.95% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.78% | ||
| ROE | 14.79% | ||
| ROIC | N/A |
ROA(3y)1.7%
ROA(5y)1.21%
ROE(3y)15.58%
ROE(5y)12.06%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin of SI (203.98%) is better than 98.94% of its industry peers.
In the last couple of years the Profit Margin of SI has grown nicely.
Looking at the Gross Margin, with a value of 76.97%, SI belongs to the top of the industry, outperforming 89.42% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | 203.98% | ||
| GM | 76.97% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y67.71%
PM growth 5Y48.16%
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
SI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SI has more shares outstanding
SI has more shares outstanding than it did 5 years ago.
There is no outstanding debt for SI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
SI has an Altman-Z score of 0.22. This is a bad value and indicates that SI is not financially healthy and even has some risk of bankruptcy.
SI has a Altman-Z score (0.22) which is comparable to the rest of the industry.
There is no outstanding debt for SI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.22 |
ROIC/WACCN/A
WACC14.74%
2.3 Liquidity
A Current Ratio of 5.52 indicates that SI has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 5.52, SI belongs to the top of the industry, outperforming 82.54% of the companies in the same industry.
SI has a Quick Ratio of 4.15. This indicates that SI is financially healthy and has no problem in meeting its short term obligations.
SI has a Quick ratio of 4.15. This is in the better half of the industry: SI outperforms 78.31% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.52 | ||
| Quick Ratio | 4.15 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 27.34% over the past year.
SI shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 43.54% yearly.
The Revenue for SI has decreased by -20.50% in the past year. This is quite bad
SI shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 25.05% yearly.
EPS 1Y (TTM)27.34%
EPS 3Y21.76%
EPS 5Y43.54%
EPS Q2Q%N/A
Revenue 1Y (TTM)-20.5%
Revenue growth 3Y16.94%
Revenue growth 5Y25.05%
Sales Q2Q%N/A
3.2 Future
Based on estimates for the next years, SI will show a very negative growth in Earnings Per Share. The EPS will decrease by -18.12% on average per year.
Based on estimates for the next years, SI will show a quite strong growth in Revenue. The Revenue will grow by 16.50% on average per year.
EPS Next Y-90.2%
EPS Next 2Y-47.1%
EPS Next 3Y-34.23%
EPS Next 5Y-18.12%
Revenue Next Year124.61%
Revenue Next 2Y53.95%
Revenue Next 3Y27.72%
Revenue Next 5Y16.5%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 3.99, the valuation of SI can be described as very cheap.
Based on the Price/Earnings ratio, SI is valued cheaper than 97.35% of the companies in the same industry.
When comparing the Price/Earnings ratio of SI to the average of the S&P500 Index (25.89), we can say SI is valued rather cheaply.
A Price/Forward Earnings ratio of 14.27 indicates a correct valuation of SI.
Compared to the rest of the industry, the Price/Forward Earnings ratio of SI indicates a rather cheap valuation: SI is cheaper than 86.77% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 34.59. SI is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 3.99 | ||
| Fwd PE | 14.27 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
SI's earnings are expected to decrease with -34.23% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.09
EPS Next 2Y-47.1%
EPS Next 3Y-34.23%
5. Dividend
5.1 Amount
No dividends for SI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
14.7
0 (0%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners57.68%
Inst Owner Change507054%
Ins Owners3.99%
Ins Owner Change73.55%
Market Cap299.29M
Revenue(TTM)90.74M
Net Income(TTM)64.50M
Analysts86.15
Price Target19.99 (35.99%)
Short Float %1.04%
Short Ratio1.54
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP50.75%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)390%
EPS NQ rev (1m)14.92%
EPS NQ rev (3m)N/A
EPS NY rev (1m)15.48%
EPS NY rev (3m)-179.97%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-75.97%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 3.99 | ||
| Fwd PE | 14.27 | ||
| P/S | 9.46 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.69 | ||
| P/tB | 0.7 | ||
| EV/EBITDA | N/A |
EPS(TTM)3.68
EY25.03%
EPS(NY)1.03
Fwd EY7.01%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS1.55
BVpS21.42
TBVpS21
PEG (NY)N/A
PEG (5Y)0.09
Graham Number42.11
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.78% | ||
| ROE | 14.79% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | 203.98% | ||
| GM | 76.97% | ||
| FCFM | N/A |
ROA(3y)1.7%
ROA(5y)1.21%
ROE(3y)15.58%
ROE(5y)12.06%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y67.71%
PM growth 5Y48.16%
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.01
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 5.52 | ||
| Quick Ratio | 4.15 | ||
| Altman-Z | 0.22 |
F-ScoreN/A
WACC14.74%
ROIC/WACCN/A
Cap/Depr(3y)95.9%
Cap/Depr(5y)75.5%
Cap/Sales(3y)10.45%
Cap/Sales(5y)6.69%
Profit Quality(3y)152.45%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)27.34%
EPS 3Y21.76%
EPS 5Y43.54%
EPS Q2Q%N/A
EPS Next Y-90.2%
EPS Next 2Y-47.1%
EPS Next 3Y-34.23%
EPS Next 5Y-18.12%
Revenue 1Y (TTM)-20.5%
Revenue growth 3Y16.94%
Revenue growth 5Y25.05%
Sales Q2Q%N/A
Revenue Next Year124.61%
Revenue Next 2Y53.95%
Revenue Next 3Y27.72%
Revenue Next 5Y16.5%
EBIT growth 1Y-22.2%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-155.27%
EBIT Next 3Y-32.17%
EBIT Next 5Y-21.81%
FCF growth 1Y-19.38%
FCF growth 3Y-7.2%
FCF growth 5YN/A
OCF growth 1Y-22.65%
OCF growth 3Y-7.32%
OCF growth 5YN/A
SHOULDER INNOVATIONS INC / SI FAQ
Can you provide the ChartMill fundamental rating for SHOULDER INNOVATIONS INC?
ChartMill assigns a fundamental rating of 5 / 10 to SI.
Can you provide the valuation status for SHOULDER INNOVATIONS INC?
ChartMill assigns a valuation rating of 4 / 10 to SHOULDER INNOVATIONS INC (SI). This can be considered as Fairly Valued.
What is the profitability of SI stock?
SHOULDER INNOVATIONS INC (SI) has a profitability rating of 5 / 10.
What is the valuation of SHOULDER INNOVATIONS INC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for SHOULDER INNOVATIONS INC (SI) is 3.99 and the Price/Book (PB) ratio is 0.69.
How sustainable is the dividend of SHOULDER INNOVATIONS INC (SI) stock?
The dividend rating of SHOULDER INNOVATIONS INC (SI) is 0 / 10 and the dividend payout ratio is 50.75%.